Evidence map›Paper›PMID 27158753›Full record

ArticleBiopreservation and biobanking2016

DNA Source Selection for Downstream Applications Based on DNA Quality Indicators Analysis.

Gema Lucena-Aguilar, Ana María Sánchez-López, Cristina Barberán-Aceituno, José Antonio Carrillo-Ávila, José Antonio López-Guerrero, Rocío Aguilar-Quesada

Abstract read
In one paragraph

Article in Biopreservation and biobanking, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed.

  1. Fecal microbiota composition is related to brown adipose tissueJournal of endocrinological investigation · 2023
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Molecular Characterization ofJournal of parasitology research · 2026
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. ApoE4 Homozygosity Is Associated With Increased Microglia Activation in Fatal COVID-19.Neuropathology : official journal of the Japanese Society of Neuropathology · 2025
    Article
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gema Lucena-Aguilar1 Andalusian Public Health System Biobank, Armilla, Spain .
Ana María Sánchez-López1 Andalusian Public Health System Biobank, Armilla, Spain .
Cristina Barberán-Aceituno1 Andalusian Public Health System Biobank, Armilla, Spain .
José Antonio Carrillo-Ávila1 Andalusian Public Health System Biobank, Armilla, Spain .
José Antonio López-Guerrero3 Laboratory of Molecular Biology, Fundación Instituto Valenciano de Oncología , Valencia, Spain .
Rocío Aguilar-Quesada1 Andalusian Public Health System Biobank, Armilla, Spain .

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-quality human DNA samples and associated information of individuals are necessary for biomedical research. Biobanks act as a support infrastructure for the scientific community by providing a large number of high-quality biological samples for specific downstream applications. For this purpose, biobank methods for sample preparation must ensure the usefulness and long-term functionality of the products obtained. Quality indicators are the tool to measure these parameters, the purity and integrity determination being those specifically used for DNA. This study analyzes the quality indicators in DNA samples derived from 118 frozen human tissues in optimal cutting temperature (OCT) reactive, 68 formalin-fixed paraffin-embedded (FFPE) tissues, 119 frozen blood samples, and 26 saliva samples. The results obtained for DNA quality are discussed in association with the usefulness for downstream applications and availability of the DNA source in the target study. In brief, if any material is valid, blood is the most approachable option of prospective collection of samples providing high-quality DNA. However, if diseased tissue is a requisite or samples are available, the recommended source of DNA would be frozen tissue. These conclusions will determine the best source of DNA, according to the planned downstream application. Furthermore our results support the conclusion that a complete procedure of DNA quantification and qualification is necessary to guarantee the appropriate management of the samples, avoiding low confidence results, high costs, and a waste of samples.

Indexed as

Biological Specimen BanksCryopreservationDNAFormaldehydeGene Expression ProfilingHumansParaffin EmbeddingProspective StudiesTissue FixationDNAFormaldehyde

Identifiers

PMID27158753
PMCPMC4991598

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.